Drug Shortage Report for TEVA-TELMISARTAN HCTZ

Last updated on 2020-05-14 History
Report ID 110788
Drug Identification Number 02379252
Brand name TEVA-TELMISARTAN HCTZ
Common or Proper name TELMISARTAN/HCTZ 80/25MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) TELMISARTAN HYDROCHLOROTHIAZIDE
Strength(s) 80.0MG 25.0MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100 & UD 30's
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-04-01
Estimated end date 2020-06-30
Actual end date 2020-05-13
Shortage status Resolved
Updated date 2020-05-14
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2020-05-14 French Compare
v9 2020-05-14 English Compare
v8 2020-05-08 French Compare
v7 2020-05-08 English Compare
v6 2020-05-08 French Compare
v5 2020-05-08 English Compare
v4 2020-04-16 French Compare
v3 2020-04-16 English Compare
v2 2020-04-03 French Compare
v1 2020-04-03 English Compare